Zorubicin
Appearance
Clinical data | |
---|---|
Trade names | rubidazon, rubidazone |
Routes of administration | i.v. |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C34H35N3O10 |
Molar mass | 645.665 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Zorubicin (INN) is a benzoylhydrazone derivative of the anthracycline antineoplastic antibiotic daunorubicin. Zorubicin intercalates into DNA; it as well interacts with topoisomerase II and inhibits DNA polymerases and therefore is used to treat cancer. [1]
References
[edit]- ^ "NCATS Inxight Drugs — ZORUBICIN". drugs.ncats.io.